share_log

海吉亞醫療：翌日披露報表

HYGEIA HEALTH: Next Day Disclosure Return

HKEX ·  Sep 3 19:06
Summary by Futu AI
海吉亞醫療控股有限公司於2024年9月3日提交了新的翌日披露報表，披露其股份變動情況。報告顯示，海吉亞醫療於2024年9月2日和9月3日進行了股份購回，分別購回1,997,200股（佔0.3163%）和98,800股（佔0.0156%），購回價格分別為每股HKD 18.2396和HKD 16.8683。經過這兩日的購回活動，公司的已發行股份總數保持不變為631,524,200股。公司確認，所有購回活動均按照香港聯合交易所有限公司的相關上市規則進行，並已獲得董事會的正式授權。此外，公司於2024年9月3日在香港聯交所購回98,800股，每股購回價介乎HKD 16.8至HKD 16.92，總支付價格為HKD 1,666,584。根據購回授權，公司可購回的股份總數為63,152,420股，截至報告日，已購回2,096,000股。購回後，公司將進入一個月的暫止期，直至2024年10月3日。
海吉亞醫療控股有限公司於2024年9月3日提交了新的翌日披露報表，披露其股份變動情況。報告顯示，海吉亞醫療於2024年9月2日和9月3日進行了股份購回，分別購回1,997,200股（佔0.3163%）和98,800股（佔0.0156%），購回價格分別為每股HKD 18.2396和HKD 16.8683。經過這兩日的購回活動，公司的已發行股份總數保持不變為631,524,200股。公司確認，所有購回活動均按照香港聯合交易所有限公司的相關上市規則進行，並已獲得董事會的正式授權。此外，公司於2024年9月3日在香港聯交所購回98,800股，每股購回價介乎HKD 16.8至HKD 16.92，總支付價格為HKD 1,666,584。根據購回授權，公司可購回的股份總數為63,152,420股，截至報告日，已購回2,096,000股。購回後，公司將進入一個月的暫止期，直至2024年10月3日。
Hygeia Health Holdings Limited submitted a new next-day disclosure report on September 3, 2024, disclosing the changes in its shareholding. The report shows that Hygeia Health repurchased 1,997,200 shares (0.3163%) and 98,800 shares (0.0156%) on September 2nd and September 3rd, 2024, respectively, at a repurchase price of HKD 18.2396 and HKD 16.8683 per share. After these two days of repurchase activity, the total number of issued shares of the company remained unchanged at 631,524,200. The company confirms that all repurchases were conducted in accordance with the relevant listing rules of the Hong Kong Stock Exchange and have obtained formal authorization from the board of directors. In addition, the company repurchased 98,800 shares on September 3, 2024, on the Hong Kong Stock Exchange at a repurchase price ranging from HKD 16.8 to HKD 16.92, with a total payment price of HKD 1,666,584. Under the repurchase authorization, the company is authorized to repurchase a total of 63,152,420 shares, and as of the report date, has repurchased 2,096,000 shares. After the repurchase, the company will enter a one-month moratorium period until October 3, 2024.
Hygeia Health Holdings Limited submitted a new next-day disclosure report on September 3, 2024, disclosing the changes in its shareholding. The report shows that Hygeia Health repurchased 1,997,200 shares (0.3163%) and 98,800 shares (0.0156%) on September 2nd and September 3rd, 2024, respectively, at a repurchase price of HKD 18.2396 and HKD 16.8683 per share. After these two days of repurchase activity, the total number of issued shares of the company remained unchanged at 631,524,200. The company confirms that all repurchases were conducted in accordance with the relevant listing rules of the Hong Kong Stock Exchange and have obtained formal authorization from the board of directors. In addition, the company repurchased 98,800 shares on September 3, 2024, on the Hong Kong Stock Exchange at a repurchase price ranging from HKD 16.8 to HKD 16.92, with a total payment price of HKD 1,666,584. Under the repurchase authorization, the company is authorized to repurchase a total of 63,152,420 shares, and as of the report date, has repurchased 2,096,000 shares. After the repurchase, the company will enter a one-month moratorium period until October 3, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.